» Articles » PMID: 17460280

Multiplex Bead Analysis of Vitreous Humor of Patients with Vitreoretinal Disorders

Overview
Specialty Ophthalmology
Date 2007 Apr 27
PMID 17460280
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Vitreoretinal disorders are frequently characterized by increased vitreous levels of cellular mediators, including cytokines, chemokines, and growth factors. The study was conducted to investigate whether multiplex bead analysis could identify disease-specific profiles of these mediators in a variety of vitreoretinal diseases.

Methods: Levels of 19 mediators were measured: the cytokines IL-6, IL-10, IL-12, IL-13, IL-15, IL-17, TNF, IFN-gamma, granulocyte-macrophage-colony-stimulating factor (GM-CSF), and granulocyte-stimulating factor (G-CSF); the chemokines CCL2, CCL3, CCL4, CCL5, CCL11, and CXCL8; and the growth factors epidermal growth factor (EGF), FGF, and VEGF, by using multiplex bead analysis of vitreous humor of 58 eyes undergoing vitrectomy for a variety of vitreoretinal disorders.

Results: The predominant mediators detected were IL-6, CXCL8, and CCL2. The most complex pattern of mediators was seen in patients with proliferative vitreoretinopathy (PVR) and included a mixture of cytokines, chemokines, and growth factors. Patients with chronic uveitis showed a limited mediator pattern that did not suggest either a Th1 or Th2 response. By comparison, patients with lens-induced uveitis (LIU) showed significantly greater levels of cytokines than did patients with chronic uveitis, including IFN-gamma and IL-12, with a trend toward an acute Th1 inflammatory response. Moreover, in samples from patients with LIU, CXCL8 inversely correlated with time after initial surgery and duration of treatment.

Conclusions: Multiplex bead analysis allows the measurement of multiple mediators from a single vitreous sample. The data confirm patterns of mediators previously described in different vitreoretinal conditions. In addition, LIU mediator levels correlate with duration of treatment and time after cataract surgery.

Citing Articles

Annexin A2 promotes proliferative vitreoretinopathy in response to a macrophage inflammatory signal in mice.

Luo M, Almeida D, Dallacasagrande V, Hedhli N, Gupta M, DAmico D Nat Commun. 2024; 15(1):8757.

PMID: 39384746 PMC: 11464875. DOI: 10.1038/s41467-024-52675-x.


Interferons in vitreoretinal diseases; a review on their clinical application, and mechanism of action.

Afarid M, Azimi A, Meshksar A, Sanie-Jahromi F Int Ophthalmol. 2024; 44(1):223.

PMID: 38727788 DOI: 10.1007/s10792-024-03144-3.


Inflammatory cytokines as mediators of retinal endothelial barrier dysfunction in non-infectious uveitis.

Ferreira L, Williams K, Best G, Haydinger C, Smith J Clin Transl Immunology. 2023; 12(12):e1479.

PMID: 38090668 PMC: 10714664. DOI: 10.1002/cti2.1479.


Vitreous humor proteome: unraveling the molecular mechanisms underlying proliferative and neovascular vitreoretinal diseases.

Dos Santos F, Ciordia S, Mesquita J, de Sousa J, Paradela A, Tomaz C Cell Mol Life Sci. 2022; 80(1):22.

PMID: 36585968 PMC: 11072707. DOI: 10.1007/s00018-022-04670-y.


Changes in aqueous and vitreous inflammatory cytokine levels in proliferative diabetic retinopathy: a systematic review and meta-analysis.

Mason R, Minaker S, Lahaie Luna G, Bapat P, Farahvash A, Garg A Eye (Lond). 2022; .

PMID: 35672457 DOI: 10.1038/s41433-022-02127-x.